RAS:RAF proximity ligation assay may predict response to KRASG12C inhibitors in NSCLC

被引：1
|
作者：
Kato, Ryoji [1 ]
Solanki, Hitendra S. [1 ]
Imbody, Denis [1 ]
Majumder, Anurima [1 ]
Stern, Yaakov [1 ]
Bridenstine, Liznair [1 ]
Johnson, Joseph [1 ]
Haura, Eric B. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
MOLECULAR CANCER RESEARCH | 2023年 / 21卷 / 05期
关键词：
D O I：
10.1158/1557-3125.RAS23-A001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A001
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The path to the clinic: a comprehensive review on direct KRASG12C inhibitors
    Kwan, Albert K.
    Piazza, Gary A.
    Keeton, Adam B.
    Leite, Caio A.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [22] Preclinical efficacy of KRASG12C inhibitors in models of pediatric cancer
    Price, Hannah
    Stauffer, Stacey
    Powell, Katie
    Baker, Andrew
    Perciaccante, Andrew
    Hernandez, Edjay Ralph
    Odeniyide, Patience
    Pratilas, Christine
    Burgan, William
    Jenkins, Lisa
    Rossman, Kent L.
    Yohe, Marielle
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [23] KRasG12C inhibitors in clinical trials: a short historical perspective
    Goebel, Lisa
    Mueller, Matthias P.
    Goody, Roger S.
    Rauh, Daniel
    RSC MEDICINAL CHEMISTRY, 2020, 11 (07): : 760 - 770
  • [24] Covalent inhibitors of the GTPase KRASG12C: a review of the patent literature
    Kettle, Jason G.
    Cassar, Doyle J.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2020, 30 (02) : 103 - 120
  • [25] Characterization of Kinetic and Redox Properties of Oncogenic KRASG12C Inhibitors
    Campbell, Sharon
    FREE RADICAL BIOLOGY AND MEDICINE, 2023, 208 : S100 - S101
  • [26] The path to the clinic: a comprehensive review on direct KRASG12C inhibitors
    Albert K. Kwan
    Gary A. Piazza
    Adam B. Keeton
    Caio A. Leite
    Journal of Experimental & Clinical Cancer Research, 41
  • [27] KRASG12C-independent feedback activation of wild-type RAS constrains KRASG12C inhibitor efficacy
    Ryan, Meagan B.
    Coker, Oluwadara
    Sorokin, Alexey
    Fella, Katerina
    Barnes, Haley
    Wong, Edmond
    Kanikarla, Preeti
    Gao, Fengqin
    Zhang, Youyan
    Zhou, Lian
    Kopetz, Scott
    Corcoran, Ryan B.
    CELL REPORTS, 2022, 39 (12):
  • [28] A next generation tri-complex KRASG12C(ON) inhibitor directly targets the active, GTP-bound state of mutant RAS and may overcome resistance to KRASG12C(OFF) inhibition.
    Nichols, Robert J.
    Cregg, Jim
    Schulze, Christopher J.
    Wang, Zhican
    Yang, Kevin
    Jiang, Jingjing
    Whalen, Daniel M.
    Hansen, Rich
    Garrenton, Lindsay S.
    Bermingham, Alun
    Knox, John E.
    Choy, Tiffany
    Reyes, Denise
    Rios, Mayra
    Seamon, Kyle
    Longhi, Michael
    Chou, Kang-Jye
    Li, Shaoling
    Wildes, David P.
    Singh, Mallika
    Koltun, Elena S.
    Gill, Adrian L.
    Smith, Jacqueline A. M.
    CANCER RESEARCH, 2021, 81 (13)
  • [29] The reactivity-driven biochemical mechanism of covalent KRASG12C inhibitors
    Rasmus Hansen
    Ulf Peters
    Anjali Babbar
    Yuching Chen
    Jun Feng
    Matthew R. Janes
    Lian-Sheng Li
    Pingda Ren
    Yi Liu
    Patrick P. Zarrinkar
    Nature Structural & Molecular Biology, 2018, 25 : 454 - 462
  • [30] The reactivity-driven biochemical mechanism of covalent KRASG12C inhibitors
    Hansen, Rasmus
    Peters, Uif
    Babbar, Anjali
    Chen, Yuching
    Feng, Jun
    Janes, Matthew R.
    Li, Lian-Sheng
    Ren, Pingda
    Liu, Yi
    Zarrinkar, Patrick P.
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2018, 25 (06) : 454 - +
12345